TAZEMETOSTAT HYDROBROMIDE

1467052-75-0

[1,1′-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4′-(4-morpholinylmethyl)-, hydrobromide (1:1)

N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4′-(4-morpholinylmethyl)-3-biphenylcarboxamide hydrobromide (1:1)

N-[(4,6-Diméthyl-2-oxo-1,2-dihydro-3-pyridinyl)méthyl]-5-[éthyl(tétrahydro-2H-pyran-4-yl)amino]-4-méthyl-4′-(4-morpholinylméthyl)-3-biphénylcarboxamide, bromhydrate (1:1)

N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4′-(4-morpholinylmethyl)-3-biphenylcarboxamidhydrobromid (1:1)

TAZEMETOSTAT HYDROBROMIDE

1467052-77-2

MFCD32201156

N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-4-methyl-4′-[(morpholin-4-yl)methyl]-[1,1′-biphenyl]-3-carboxamide hydrobromide

N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide;hydrobromide

Tazemetostat HBr

Tazverik